盐酸坦索罗辛治疗良性前列腺增生疗效观察

Tamsulosin Efficacy of treatment of benign prostatic hyperplasia

目的：观察比较盐酸坦索罗辛治疗良性前列腺增生的疗效。方法将我院2008年3月。2010年3月86例良性前列腺增生患者随机分成两组，分别为观察组（盐酸坦索罗辛组43例）和对照组（盐酸四喃唑嗪组43例），观察比较两组的临床疗效。结果：观察组与对照组比较，IPSS评分明显降低、残余尿量明显减少、最大尿流率明显增加（P〈0．05），且治疗过程中无明显不良反应发生。结论：盐酸坦索罗辛治疗良性前列腺增生疗效确切，值得临床推广和应用。

Objective：To compare the tamsulosin treatment of benign prostatic byperplasia.Methods：86 patients with benign prostatic hyperplasia were randomly divided into two groups,namely the observation group （tamsulosin group 43 cases） and control group （hydralazine hydrochloride four furan yl group 43 cases）, observe and compare the clinical efficacy of the two groups . The results observed compared with the control group, IPSS score decreased, residual urine volume decreased, maximum flow rate increased significantly （P〈0. 05）,and the course of treatment no significant adverse reactions.Conclusion The treatment of benign prostatic hyperplasia tamsulosin is effective and is worthy of promotion and application.